Why the study?
Does natriuretic peptide assessment improve early detection and prevention of decompensation and rehospitalization in post-acute heart failure patients?
Does natriuretic peptide assessment improve early detection and prevention of decompensation and rehospitalization in post-acute heart failure patients?
Natriuretic peptide assessment may play an important role in monitoring dynamic physiological changes and preventing rehospitalization in post-acute heart failure patients.
Hypothesis-generating for natriuretic peptide monitoring in post-acute HF; prospective trials needed before clinical adoption.
Heart failure is a chronic disease marked by variable acute exacerbations. Once hospitalized the decompensated patient may have signs and symptoms only partially reversed, medical therapy only partially optimized and deranged physiology only partially restored. Therefore, the post-acute care period is one of unique vulnerability and merits efforts of careful and comprehensive assessment of patients at risk of recurrent decompensation and rehospitalization. Natriuretic peptide (NP) assessment which has the ability to monitor dynamic changes in a patient's physiology, may play an important role as part of a post-acute care algorithm focused on early detection and prevention of further decompensation and rehospitalization.
No takes yet. Share an insight, caveat, or question.
Maisel et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: